German pharmaceutical company Stada Arzneimittel is intended to be fully acquired by either Cinven Partners and Advent International Corporation, which have both submitted bids.
“US-based biopharmaceutical company NexImmune has been fully acquired by a consortium of private investors.”
Both companies that bid for the acquisition are based in the US.
Go deeper with GlobalData
US-based biopharmaceutical company NexImmune has been fully acquired by a consortium of private investors.
The acquisition will help NexImmune expand its portfolio in immuno-oncology and other immune-mediated disease areas.
The consortium, led by Celgene and CEOs of Medtronic, also includes other private investors.
GlobalData Strategic Intelligence
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
